What the ATC L01 notices indicate for the supply chain The 164 consolidated notices from Germany, Czechia, Belgium, Austria, Denmark are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
GDP-capable pharmaceutical storage in Cheb Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Review pharmaceutical storage in Czechia → Germany Updated 09.11.2026 Ixoten Active ingredient: Trofosfamid
View notice details → Czechia Updated 09.11.2026 DOCETAXEL KABI 80MG/4ML INF CNC SOL 1X4ML Active ingredient: DOCETAXEL
View notice details → Belgium Updated 09.11.2026 Mektovi 45 mg film-coat. tabl. 28 Active ingredient: Binimetinib
View notice details → Belgium Updated 09.11.2026 Hydrea 500 mg hard caps. 20 Active ingredient: Hydroxycarbamide
View notice details → Belgium Updated 09.11.2026 Docetaxel Accord 80 mg/4 ml inf. sol. (conc.) i.v. vial 4 ml Active ingredient: Docetaxel
View notice details → Belgium Updated 09.11.2026 Azacitidin Sandoz 25 mg/ml inj. susp. (pwdr.) s.c. vial 100 mg Active ingredient: Azacitidine
View notice details → Czechia Updated 06.11.2026 PAZOPANIB ACCORD 200MG TBL FLM 30 Active ingredient: PAZOPANIB
View notice details → Czechia Updated 06.11.2026 GEMCITABIN EBEWE 40MG/ML INF CNC SOL 1X50ML II Active ingredient: GEMCITABIN
View notice details → Germany Updated 05.11.2026 Carboplatin Accord 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Carboplatin
View notice details → Germany Updated 05.11.2026 Bortezomib STADA 2,5 mg/ml Injektionslösung Active ingredient: Bortezomibmannitol
View notice details → Czechia Updated 05.11.2026 CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X60ML+PLAST Active ingredient: KARBOPLATINA
View notice details → Belgium Updated 05.11.2026 Docetaxel Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 4 ml Active ingredient: Docetaxel
View notice details → Belgium Updated 05.11.2026 Docetaxel Accord 160 mg/8 ml inf. sol. (conc.) i.v. vial 8 ml Active ingredient: Docetaxel
View notice details → Belgium Updated 05.11.2026 Carboplatin Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial 60 ml Active ingredient: Carboplatin
View notice details → Czechia Updated 04.11.2026 TOLAK 40MG/G CRM 20G Active ingredient: FLUORURACIL
View notice details → Belgium Updated 04.11.2026 Jevtana 60 mg inf. sol. (conc. + solv.) i.v. vial 1.5 ml + 4.5 ml Active ingredient: Cabazitaxel
View notice details → Czechia Updated 03.11.2026 ETOPOSID EBEWE 20MG/ML INF CNC SOL 1X10ML Active ingredient: ETOPOSID
View notice details → Czechia Updated 03.11.2026 ENDOXAN 1G INJ/INF PLV SOL 1 Active ingredient: CYKLOFOSFAMID
View notice details → Belgium Updated 03.11.2026 Sorafenib Sandoz 200 mg film-coat. tabl. 112 (112 x 1) UD Active ingredient: Sorafenib
View notice details → Belgium Updated 03.11.2026 Sorafenib EG 200 mg film-coat. tabl. 112 Active ingredient: Sorafenib
View notice details → Belgium Updated 03.11.2026 Gemcitabine Accord Healthcare 100 mg/ml inf. sol. (conc.) i.v. vial 2 ml Active ingredient: Gemcitabine
View notice details → Czechia Updated 02.11.2026 OXALIPLATIN KABI 5MG/ML INF CNC SOL 1X10ML Active ingredient: OXALIPLATINA
View notice details → Belgium Updated 02.11.2026 Topotecan Accord Healthcare 1 mg/ml inf. sol. (conc.) i.v. vial 1 ml Active ingredient: Topotecan
View notice details → Belgium Updated 02.11.2026 Mitomycin Accord Healthcare 10 mg inj./inf. sol. (pwdr.)/i.vesic. sol. (pwdr.) i.v. vial 5 x 10 mg Active ingredient: Mitomycin
View notice details → Belgium Updated 30.10.2026 Methotrexate Accord Healthcare 25 mg/ml inj. sol. i.m./i.thec./i.v./i.arter. vial 2 ml Active ingredient: Methotrexate
View notice details → Belgium Updated 30.10.2026 Erwinase 10 000 U inj./inf. sol. (pwdr.) i.m./i.v. vial 5 x 10000 U Active ingredient: Crisantaspase
View notice details → Belgium Updated 30.10.2026 Brukinsa 80 mg hard caps. 120 Active ingredient: Zanubrutinib
View notice details → Czechia Updated 29.10.2026 PAZOPANIB ACCORD 200MG TBL FLM 30 Active ingredient: PAZOPANIB
View notice details → Czechia Updated 29.10.2026 HOLOXAN 1G INF PLV SOL 5X1 Active ingredient: IFOSFAMID
View notice details → Czechia Updated 29.10.2026 CARBOPLATIN ACCORD 10MG/ML INF CNC SOL 1X60ML/600MG Active ingredient: KARBOPLATINA
View notice details → Austria Updated 29.10.2026 Braftovi 75 mg Hartkapseln Active ingredient: ENCORAFENIB
View notice details → Czechia Updated 28.10.2026 SUNITINIB PHARMAGEN 25MG CPS DUR 30 Active ingredient: SUNITINIB
View notice details → Belgium Updated 27.10.2026 Topotecan Accord Healthcare 1 mg/ml inf. sol. (conc.) i.v. vial 1 ml Active ingredient: Topotecan
View notice details → Belgium Updated 26.10.2026 Holoxan 1 g inj. sol. (pwdr.) i.v. vial 10 x 1000 mg Active ingredient: Ifosfamide
View notice details → Belgium Updated 26.10.2026 Endoxan 500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial 5 x 500 mg Active ingredient: Cyclophosphamide
View notice details → Belgium Updated 26.10.2026 Endoxan 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 1000 mg Active ingredient: Cyclophosphamide
View notice details → Belgium Updated 26.10.2026 Efudix 5 % ointm. 20 g Active ingredient: Fluorouracil
View notice details → Belgium Updated 23.10.2026 Emthexate 50 mg/2 ml inj. sol. i.m./i.thec./i.ventricul./i.v./i.arter. vial 2 ml Active ingredient: Methotrexate
View notice details → Austria Updated 22.10.2026 Anagrelid ratiopharm 1 mg Hartkapseln Active ingredient: ANAGRELIDHYDROCHLORID MONOHYDRAT
View notice details → Czechia Updated 21.10.2026 DOCETAXEL KABI 20MG/1ML INF CNC SOL 1X1ML Active ingredient: DOCETAXEL
View notice details → Austria Updated 21.10.2026 Everolimus HCS 2,5 mg Tabletten Active ingredient: EVEROLIMUS
View notice details → Belgium Updated 20.10.2026 Busulfan Fresenius Kabi 6 mg/ml inf. sol. (conc.) i.v. vial 8 x 10 ml Active ingredient: Busulfan
View notice details → Germany Updated 19.10.2026 Pazopanib Viatris 200 mg Filmtabletten Active ingredient: Pazopanibhydrochlorid
View notice details → Germany Updated 16.10.2026 Luxerm Active ingredient: Methylaminolevulinat
View notice details → Czechia Updated 16.10.2026 DOCETAXEL EBEWE 10MG/ML INF CNC SOL 1X2ML I Active ingredient: DOCETAXEL
View notice details → Belgium Updated 16.10.2026 Erlotinib Sandoz 100 mg film-coat. tabl. 30 Active ingredient: Erlotinib
View notice details → Belgium Updated 16.10.2026 Epirubicin Eugia 2 mg/ml inj. sol. i.v. vial 25 ml Active ingredient: Epirubicin
View notice details → Belgium Updated 16.10.2026 Epirubicin Eugia 2 mg/ml inj. sol. i.v. vial 100 ml Active ingredient: Epirubicin
View notice details → Germany Updated 15.10.2026 Mektovi 15 mg Filmtabletten Active ingredient: Binimetinib
View notice details → Belgium Updated 15.10.2026 Trabectedine Teva 1 mg inj. sol. (pwdr., conc.) i.v. vial 1 mg Active ingredient: Trabectedin
View notice details → Germany Updated 14.10.2026 Nipent 10 mg Pulver zur Herstellung einer Injektionlösung/Infusionslösung Active ingredient: Pentostatin
View notice details → Czechia Updated 14.10.2026 SORAFENIB ZENTIVA 200MG TBL FLM 112X1 Active ingredient: SORAFENIB
View notice details → Czechia Updated 14.10.2026 ETOPOSIDE ACCORD 20MG/ML INF CNC SOL 1X12,5ML Active ingredient: ETOPOSID
View notice details → Belgium Updated 14.10.2026 Imatinib Teva 100 mg film-coat. tabl. 120 (120 x 1) UD Active ingredient: Imatinib
View notice details → Belgium Updated 14.10.2026 Doxorubicin Accord Healthcare 2 mg/ml inf. sol. (conc.) i.v. vial 100 ml Active ingredient: Doxorubicin Hydrochloride
View notice details → Germany Updated 13.10.2026 Carboplatin Hikma 10 mg/ml Infusionslösung Active ingredient: Carboplatin
View notice details → Austria Updated 13.10.2026 Sunitinib Teva 25 mg Hartkapseln Active ingredient: SUNITINIB
View notice details → Germany Updated 12.10.2026 Everolimus-ratiopharm 2,5 mg Tabletten Active ingredient: Everolimus
View notice details → Belgium Updated 12.10.2026 Carboplatin Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial 15 ml Active ingredient: Carboplatin
View notice details → Belgium Updated 12.10.2026 Capecitabine Accord 500 mg film-coat. tabl. 120 (120 x 1) UD Active ingredient: Capecitabine
View notice details → Germany Updated 09.10.2026 Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Cisplatin
View notice details → Germany Updated 08.10.2026 Dacarbazin Lipomed 1000 mg Pulver zur Herstellung einer Infusionslösung Active ingredient: Dacarbazincitrat
View notice details → Germany Updated 08.10.2026 Arsentrioxid STADA 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Arsen(III)-oxid
View notice details → Belgium Updated 08.10.2026 Siklos 100 mg film-coat. tabl. 60 Active ingredient: Hydroxycarbamide
View notice details → Czechia Updated 07.10.2026 DASATINIB VIATRIS 50MG TBL FLM 60 Active ingredient: DASATINIB
View notice details → Czechia Updated 07.10.2026 CAELYX PEGYLATED LIPOSOMAL 2MG/ML INF CNC SOL 1X10ML Active ingredient: DOXORUBICIN
View notice details → Czechia Updated 06.10.2026 TABRECTA 200MG TBL FLM 120 Active ingredient: KAPMATINIB
View notice details → Czechia Updated 06.10.2026 CABAZITAXEL SANDOZ 10MG/ML INF CNC SOL 1X6ML Active ingredient: KABAZITAXEL
View notice details → Czechia Updated 05.10.2026 VINCRISTINE TEVA 1MG/ML INJ SOL 1X1ML Active ingredient: VINKRISTIN
View notice details → Czechia Updated 05.10.2026 OXALIPLATIN KABI 5MG/ML INF CNC SOL 1X10ML Active ingredient: OXALIPLATINA
View notice details → Belgium Updated 05.10.2026 Imatinib Teva 400 mg film-coat. tabl. 30 (30 x 1) UD Active ingredient: Imatinib
View notice details → Germany Updated 02.10.2026 Eldisine Active ingredient: Vindesinsulfat
View notice details → Czechia Updated 02.10.2026 AZACITIDIN MYLAN 25MG/ML INJ PLV SUS 1X100MG Active ingredient: AZACITIDIN
View notice details → Belgium Updated 02.10.2026 Xeloda 150 mg tabl. 60 Active ingredient: Capecitabine
View notice details → Germany Updated 01.10.2026 Nilotinib Viatris 50 mg Hartkapseln Active ingredient: Nilotinibhydrochlorid-Dihydrat
View notice details → Czechia Updated 30.09.2026 CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X45ML+PLAST Active ingredient: KARBOPLATINA
View notice details → Belgium Updated 30.09.2026 Xeloda 500 mg tabl. 120 Active ingredient: Capecitabine
View notice details → Belgium Updated 30.09.2026 Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 25 ml Active ingredient: Doxorubicin Hydrochloride
View notice details → Belgium Updated 30.09.2026 Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 10 ml Active ingredient: Doxorubicin Hydrochloride
View notice details → Denmark Updated 29.09.2026 Ogivri 420 mg pulver til koncentrat til infusionsvæske, opløsning Active ingredient: Trastuzumab
View notice details → Germany Updated 29.09.2026 Cyclophosphamid HEXAL 500 mg Active ingredient: Cyclophosphamid Monohydrat
View notice details → Germany Updated 28.09.2026 Carboplatin Hikma 10 mg/ml Infusionslösung Active ingredient: Carboplatin
View notice details → Belgium Updated 28.09.2026 Zykadia 150 mg hard caps. 150 (3 x 50) Active ingredient: Ceritinib
View notice details → Belgium Updated 28.09.2026 Jevtana 60 mg inf. sol. (conc. + solv.) i.v. vial 1.5 ml + 4.5 ml Active ingredient: Cabazitaxel
View notice details → Germany Updated 25.09.2026 Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Oxaloplatin
View notice details → Germany Updated 24.09.2026 Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Cisplatin
View notice details → Belgium Updated 22.09.2026 Pemetrexed Accord 25 mg/ml inf. sol. (conc.) i.v. vial 20 ml Active ingredient: Pemetrexed
View notice details → Belgium Updated 22.09.2026 Fluorouracil Accord Healthcare 50 mg/ml inj./inf. sol. i.v./i.arter. vial 20 ml Active ingredient: Fluorouracil
View notice details → Belgium Updated 22.09.2026 Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial 12.5 ml Active ingredient: Etoposide
View notice details → Austria Updated 22.09.2026 Capecitabin Sandoz 500 mg - Filmtabletten Active ingredient: CAPECITABIN
View notice details → Germany Updated 21.09.2026 Cyclophosphamid HEXAL 500 mg Active ingredient: Cyclophosphamid Monohydrat
View notice details → Czechia Updated 21.09.2026 ZYNYZ 500MG INF CNC SOL 1X20ML Active ingredient: RETIFANLIMAB
View notice details → Czechia Updated 18.09.2026 CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X60ML+PLAST Active ingredient: KARBOPLATINA
View notice details → Czechia Updated 17.09.2026 DASATINIB VIATRIS 20MG TBL FLM 60 Active ingredient: DASATINIB
View notice details → Belgium Updated 17.09.2026 Eribulin Baxter 0.44 mg/ml inj. sol. i.v. vial 2 ml Active ingredient: Eribulin
View notice details → Austria Updated 17.09.2026 Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: OXALIPLATIN
View notice details → Belgium Updated 16.09.2026 Rozlytrek 100 mg hard caps. 30 Active ingredient: Entrectinib
View notice details → Belgium Updated 16.09.2026 Imatinib Teva 400 mg film-coat. tabl. 30 (30 x 1) UD Active ingredient: Imatinib
View notice details → Belgium Updated 16.09.2026 Etoposide Accord Healthcare 20 mg/ml inf. sol. (conc.) i.v. vial 5 ml Active ingredient: Etoposide
View notice details → Belgium Updated 16.09.2026 Bleomycine Hikma 15 000 IU inj. sol. (pwdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. vial 15000 IU Active ingredient: Bleomycin Sulfate
View notice details → Belgium Updated 15.09.2026 Mitoxantrone Sandoz 2 mg/ml inf. sol. (conc.) i.v. vial 5 ml Active ingredient: Mitoxantrone
View notice details → Belgium Updated 15.09.2026 Caelyx Pegylated Liposomal 2 mg/ml inf. sol. (conc.) i.v. vial 25 ml Active ingredient: Doxorubicin Hydrochloride
View notice details → Belgium Updated 14.09.2026 Rozlytrek 100 mg hard caps. 30 Active ingredient: Entrectinib
View notice details → Belgium Updated 14.09.2026 Gemcitabine Accord Healthcare 100 mg/ml inf. sol. (conc.) i.v. vial 10 ml Active ingredient: Gemcitabine
View notice details → Czechia Updated 11.09.2026 MEKINIST 0,5MG TBL FLM 30 Active ingredient: TRAMETINIB
View notice details → Czechia Updated 11.09.2026 DOCETAXEL KABI 80MG/4ML INF CNC SOL 1X4ML Active ingredient: DOCETAXEL
View notice details → Czechia Updated 11.09.2026 DOCETAXEL ACCORD 20MG/1ML INF CNC SOL 1X1ML Active ingredient: DOCETAXEL
View notice details → Czechia Updated 11.09.2026 DOCETAXEL ACCORD 160MG/8ML INF CNC SOL 1X8ML Active ingredient: DOCETAXEL
View notice details → Czechia Updated 11.09.2026 CARBOPLATIN ACCORD 10MG/ML INF CNC SOL 1X60ML/600MG Active ingredient: KARBOPLATINA
View notice details → Czechia Updated 11.09.2026 CARBOPLATIN ACCORD 10MG/ML INF CNC SOL 1X15ML/150MG Active ingredient: KARBOPLATINA
View notice details → Belgium Updated 11.09.2026 Bleomycine Hikma 15 000 IU inj. sol. (pwdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. vial 15000 IU Active ingredient: Bleomycin Sulfate
View notice details → Germany Updated 10.09.2026 Everolimus-ratiopharm 2,5 mg Tabletten Active ingredient: Everolimus
View notice details → Czechia Updated 10.09.2026 NINTEDANIB SANDOZ 100MG CPS MOL 30X1 Active ingredient: NINTEDANIB
View notice details → Austria Updated 10.09.2026 Caelyx 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: DOXORUBICIN HYDROCHLORID
View notice details → Belgium Updated 09.09.2026 Capecitabine Accord 150 mg film-coat. tabl. 60 (60 x 1) UD Active ingredient: Capecitabine
View notice details → Czechia Updated 08.09.2026 PYZYPI 400MG TBL FLM 60 Active ingredient: PAZOPANIB
View notice details → Czechia Updated 08.09.2026 CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X15ML+PLAST Active ingredient: KARBOPLATINA
View notice details → Belgium Updated 08.09.2026 Vinorelbine Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial 5 ml Active ingredient: Vinorelbine
View notice details → Belgium Updated 08.09.2026 Efudix 5 % ointm. 20 g Active ingredient: Fluorouracil
View notice details → Belgium Updated 08.09.2026 Cytarabine Accord Healthcare 100 mg/ml inj./inf. sol. i.v./s.c. vial 10 ml Active ingredient: Cytarabine
View notice details → Austria Updated 08.09.2026 Lonsurf 20 mg/8,19 mg Filmtabletten Active ingredient: TIPIRACIL HYDROCHLORID, TRIFLURIDIN
View notice details → Austria Updated 08.09.2026 Lonsurf 15 mg/6,14 mg Filmtabletten Active ingredient: TIPIRACIL HYDROCHLORID, TRIFLURIDIN
View notice details → Germany Updated 04.09.2026 Nilotinib Viatris 50 mg Hartkapseln Active ingredient: Nilotinibhydrochlorid-Dihydrat
View notice details → Czechia Updated 04.09.2026 CARBOPLATIN KABI 10MG/ML INF CNC SOL 1X5ML+PLAST Active ingredient: KARBOPLATINA
View notice details → Germany Updated 03.09.2026 Busulfan-ratiopharm 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Busulfan
View notice details → Belgium Updated 03.09.2026 Eribulin Baxter 0.44 mg/ml inj. opl. i.v. flac. 2 ml Active ingredient: Eribulin
View notice details → Belgium Updated 03.09.2026 Cytarabine Accord Healthcare 100 mg/ml inj./inf. opl. i.v./s.c. flac. 10 ml Active ingredient: Cytarabine
View notice details → Germany Updated 02.09.2026 Sunitinib AL 12,5 mg Hartkapseln Active ingredient: Sunitinib
View notice details → Germany Updated 02.09.2026 ARA-cell 40mg Injektion Active ingredient: Cytarabin
View notice details → Germany Updated 02.09.2026 ARA-cell 4000mg Infusionslösung Active ingredient: Cytarabin
View notice details → Germany Updated 02.09.2026 ARA-cell 1000mg Infusionslösung Active ingredient: Cytarabin
View notice details → Germany Updated 02.09.2026 ARA-cell 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Cytarabin
View notice details → Czechia Updated 02.09.2026 GEMCITABIN EBEWE 40MG/ML INF CNC SOL 1X50ML II Active ingredient: GEMCITABIN
View notice details → Belgium Updated 02.09.2026 Trabectedin Accord 0.25 mg inf. opl. (pdr., conc.) i.v. flac. 0.25 mg Active ingredient: Trabectedin
View notice details → Belgium Updated 02.09.2026 Colchicine Opocalcium 1 mg tabl. 20 Active ingredient: Colchicine
View notice details → Czechia Updated 01.09.2026 TEPKINLY 4MG/0,8ML INJ SOL 1 Active ingredient: EPKORITAMAB
View notice details → Czechia Updated 01.09.2026 TEPKINLY 48MG INJ SOL 1 Active ingredient: EPKORITAMAB
View notice details → Belgium Updated 01.09.2026 Bleomycine Hikma 15 000 IE inj. opl. (pdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. flac. 15000 IE Active ingredient: Bleomycin Sulfate
View notice details → Belgium Updated 01.09.2026 Bendamustine Accord 25 mg/ml inf. opl. (conc.) i.v. flac. 5 x 4 ml Active ingredient: Bendamustine Hydrochloride
View notice details → Czechia Updated 31.08.2026 GEMCITABINE ACCORD 100MG/ML INF CNC SOL 1X2ML Active ingredient: GEMCITABIN
View notice details → Czechia Updated 31.08.2026 DOCETAXEL ACCORD 80MG/4ML INF CNC SOL 1X4ML Active ingredient: DOCETAXEL
View notice details → Belgium Updated 31.08.2026 Nintedanib Accord 150 mg zachte caps. 60 (60 x 1) UD Active ingredient: Nintedanib
View notice details → Belgium Updated 31.08.2026 Nintedanib Accord 100 mg zachte caps. 60 (60 x 1) UD Active ingredient: Nintedanib
View notice details → Belgium Updated 31.08.2026 Etoposide Accord Healthcare 20 mg/ml inf. opl. (conc.) i.v. flac. 5 ml Active ingredient: Etoposide
View notice details → Belgium Updated 31.08.2026 Etoposide Accord Healthcare 20 mg/ml inf. opl. (conc.) i.v. flac. 12.5 ml Active ingredient: Etoposide
View notice details → Belgium Updated 31.08.2026 Carboplatin Accord Healthcare 10 mg/ml inf. opl. (conc.) i.v. flac. 15 ml Active ingredient: Carboplatin
View notice details → Czechia Updated 28.08.2026 DOCETAXEL KABI 20MG/1ML INF CNC SOL 1X1ML Active ingredient: DOCETAXEL
View notice details → Belgium Updated 28.08.2026 Mitoxantrone Sandoz 2 mg/ml inf. opl. (conc.) i.v. flac. 5 ml Active ingredient: Mitoxantrone
View notice details → Germany Updated 27.08.2026 IFO-cell N 2000 Active ingredient: Ifosfamid
View notice details → Germany Updated 27.08.2026 IFO-cell N 1000 Active ingredient: Ifosfamid
View notice details → Germany Updated 27.08.2026 IFO-cell 5 g Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Ifosfamid
View notice details → Germany Updated 27.08.2026 IFO-cell 2g Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Ifosfamid
View notice details → Belgium Updated 27.08.2026 Erbitux 5 mg/ml inf. opl. i.v. flac. 20 ml Active ingredient: Cetuximab
View notice details → Belgium Updated 27.08.2026 Erbitux 5 mg/ml inf. opl. i.v. flac. 100 ml Active ingredient: Cetuximab
View notice details → Belgium Updated 27.08.2026 Caelyx Pegylated Liposomal 2 mg/ml inf. opl. (conc.) i.v. flac. 25 ml Active ingredient: Doxorubicin Hydrochloride
View notice details → Austria Updated 25.08.2026 Sarclisa 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: ISATUXIMAB
View notice details → Germany Updated 21.08.2026 Bortezomib STADA 2,5 mg/ml Injektionslösung Active ingredient: Bortezomibmannitol
View notice details → Austria Updated 21.08.2026 Temodal 250 mg Hartkapseln Active ingredient: TEMOZOLOMID
View notice details → Czechia Updated 20.08.2026 ZOLSKETIL PEGYLATED LIPOSOMAL 2MG/ML INF CNC DIS 1X25ML Active ingredient: DOXORUBICIN
View notice details → Germany Updated 19.08.2026 Pazopanib Viatris 400 mg Filmtabletten Active ingredient: Pazopanibhydrochlorid
View notice details → Germany Updated 19.08.2026 Braftovi 50 mg Hartkapseln Active ingredient: Encorafenib
View notice details → Germany Updated 18.08.2026 Mitem 20mg Active ingredient: Mitomycin
View notice details → Germany Updated 17.08.2026 Eldisine Active ingredient: Vindesinsulfat
View notice details → Germany Updated 17.08.2026 Arsentrioxid STADA 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung Active ingredient: Arsen(III)-oxid
View notice details →